Noroxymorphone,Patient Information,Drugs Information,Details,Side Effects,Consumer Information,Injection Manufacaturer,Drug Interaction,Drugs Side Effects,Medicines Exporters,Precaution,Causes,Consumer Information,Causes,Importer,Drug Exporters in India,Causes,Uses,Raw Material Suppliers, Fda Approval,Taj Pharmaceuticals Ltd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Noroxymorphone-top taj Pharmaceuticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Noroxymorphone Manufacturers in India Suppliers Noroxymorphone Exporters Distributors Noroxymorphone api active pharmaceuticals ingredients Noroxymorphone manufacturers Side Effects bulk drugs raw material Noroxymorphone companies Side Effects Importers Noroxymorphone Noroxymorphone Exporters Noroxymorphone exporters FDA Noroxymorphone DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Noroxymorphone manufacturing pharmaceutical drugs pharmaceutical intermediates Noroxymorphone pharmaceutical chemicals pharmaceutical raw materials Noroxymorphone active pharmaceutical ingredients Noroxymorphone committee active pharmaceutical ingredients manufacturer Noroxymorphone Active Pharmaceutical Ingredients manufacturer Noroxymorphone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Noroxymorphone, Noroxymorphone manufacturer India, Noroxymorphone product, Noroxymorphone products, Api preparation, Certificate of Analysis API manufacturer product, Noroxymorphone anti ulcer product, Certificate of Origin COA Noroxymorphone COS Noroxymorphone, pharmaceutical generic, pharmaceutical drug, medical, Noroxymorphone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Noroxymorphone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Noroxymorphone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Noroxymorphone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Noroxymorphone ingredients, api, HIV Noroxymorphone, tablets, capsules, syrup & protein Noroxymorphone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Noroxymorphone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Noroxymorphone WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Noroxymorphone

HOME >> API >> API List 4 >> Noroxymorphone >> Patient Information

PATIENT INFORMATION
Noroxymorphone CAS No.: 33522-95-1

Parent Case Data:

This application is a continuation-in-part of application Ser. No. 196,539, filed Jul. 18, 1988, now agandoned, which was a continuation of application Ser. No. 863,209, filed May 14, 1986, now abandoend, which was a continuation of application Ser. No. 713,932, filed Mar. 20, 1985, now abandoned, which was a continuation-in-part of application Ser. No. 593,744, filed Mar. 27, 1984, now abandoned, which is incorporated herein by reference.
Claims:
What is claimed is:

1. A process for preparing noroxymorphone from morphine comprising:

(1) reacting morphine in a single step with a haloformate ester of the formula X--C(O)OR1, wherein X is halogen and R1 is alkyl, so as to form 3,17-(di-R1 -oxycarbonyl)normorphine;

(2) oxidizing the hydroxyl group of the 3,17-(di-R1 -oxycarbonyl)normophine with an oxidizing agent, under acidic conditions at a pH of less than 1.0, so as to form 3,17-(di-R1 -oxycarbonyl)normorphinone;

(3) acylating the 3,17-(di-R1 -oxycarbonyl) normophinone with an acylating agent so as to form 3,17-(di-R1 -oxycarbonyl)normorphinone dienol acylate;

(4) contacting the dienol acylate with a peroxy oxidation agent so as to introduce a beta-oriented hydroxyl group in position 14 of said dienol acylate, so as to form 14-hydroxy 3,17-(di-R1 -oxycarbonyl)normorphinone;

(5) hydrogenating the 14-hydroxy-3,17-(di-R1 -oxycarbonyl)normorphinone in a reduction reaction so as to form 3,17-(di-R1 -oxycarbonyl)noroxymorphinone; and

(6) hydrolysing the 3,17-(di-R1 -oxycarbonyl) noroxymorphinone under hydrolytic conditions, so as to form noroxymorphone.

Information Associated with Product:

DRUG DESCRIPTION

OTHER INFORMATION

PATIENT INFORMATION >>

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing in India

Acenocoumarol	Aluminium-magnesium	Buprenorphine HCl	Dihydrocodeine hydrogentartrate	Ethylmorphine HCl	Glibornuride	Hydroxychloroquine sulphate	Noroxymorphone	Noscapine base
Oxycodone	Oxymorphone	Phenobarbital acid	Phenobarbital sodium	Thebaine

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.